Insider sale
TAYSHA GENE THERAPIES, INC.
$225.9K
47.88K shares
What this filing means
MCAULIFFE SEAN plans to sell 47.88K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $225.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001979693-26-000007
47.88K
Shares to sell
$225.9K
Approx. market value
914.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
2/3/2026
914.00Total acquired914.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 914.00 | — |
| Total | 914.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10.89K
Market value
$50.2K
1/26/2026
—Completed
Units to sell
36.07K
Market value
$171.3K
1/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
914.00
Market value
$4.3K
2/4/2026
Total
Units
47.88K
Value
$225.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 10.89K | $50.2K | — | Completed |
1/23/2026 | 36.07K | $171.3K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 914.00 | $4.3K | Nasdaq | Planned |
| Total | 47.88K | $225.9K | ||